Mathias Altmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mathias Altmann has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Ronan Jambou
Centre de Recherche Médicale et Sanitaire, Niamey, Niger
2 shared publications - Alexandra Bastaraud
Food and Environmental Hygiene Laboratory, Institut Pasteur de Madagascar, Antananarivo 101, Madagascar
1 shared publication - Alexandre Manirakiza
Institut Pasteur of Bangui, Pasteur International Network
1 shared publication - André Briend
Tampere Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Tampere, Finland
1 shared publication Aruna Aaron
Ministry of Health, Kinshasa, Democratic Republic of Congo
1 shared publicationAyuko Hirai
National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, University of Bordeaux, Bordeaux, France
1 shared publication
Latest Publications
- Open Access
- 4 February 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Challenges in strengthening sentinel surveillance network during COVID-19 pandemic in Africa
The emergence of variants in the wake of the COVID-19 pandemic has put a strain on healthcare systems in Africa. The Afroscreen project is strengthening national sentinel surveillance systems, combined with sequencing capabilities to identify potentially highly virulent variants of interest at an early stage. The aim of this article is to present the results of this project and discuss the related challenges. Surveillance was based on national surveillance sentinel systems, either hospital-based or peripheral, and RT-PCR diagnostic capabilities, coupled with sequencing in the event of positivity, from July 2022 to June 2024. In 11 African countries (Senegal, Guinea, Côte d’Ivoire, Togo, Benin, Niger, Cameroon, the Central African Republic (CAR), Burkina Faso, Madagascar and the Democratic Republic of the Congo), it was possible to demonstrate a decline in the circulation of SARS-CoV-2 over the surveillance period, with only the Omicron variant circulating. Setting up and coordinating a multicountry sentinel surveillance system during a pandemic period is a real challenge. This highlights the need to strengthen surveillance systems during interepidemic and pandemic periods and the question of their sustainability in line with emerging disease preparedness and response programs.
- 4 February 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessChallenges in strengthening sentinel surveillance network during COVID-19 pandemic in Africa
The emergence of variants in the wake of the COVID-19 pandemic has put a strain on healthcare systems in Africa. The Afroscreen project is strengthening national sentinel surveillance systems, combined with sequencing capabilities to identify potentially highly virulent variants of interest at an early stage. The aim of this article is to present the results of this project and discuss the related challenges. Surveillance was based on national surveillance sentinel systems, either hospital-based or peripheral, and RT-PCR diagnostic capabilities, coupled with sequencing in the event of positivity, from July 2022 to June 2024. In 11 African countries (Senegal, Guinea, Côte d’Ivoire, Togo, Benin, Niger, Cameroon, the Central African Republic (CAR), Burkina Faso, Madagascar and the Democratic Republic of the Congo), it was possible to demonstrate a decline in the circulation of SARS-CoV-2 over the surveillance period, with only the Omicron variant circulating. Setting up and coordinating a multicountry sentinel surveillance system during a pandemic period is a real challenge. This highlights the need to strengthen surveillance systems during interepidemic and pandemic periods and the question of their sustainability in line with emerging disease preparedness and response programs.
- Open Access
- 19 November 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1669745
Evaluating the performance of digital surveillance for epidemic-prone diseases in Kwango Province, Democratic Republic of Congo
Background: Strengthening infectious disease surveillance systems is critical to prevent the spread of diseases, particularly in resource-limited settings. Digital health tools such as the Surveillance Outbreak Response Management and Analysis System (SORMAS) offer real-time reporting and data management. This study assessed the performance of SORMAS in Kwango Province, Democratic Republic of Congo (DRC), focusing on two implementation models: facility-level model, where health workers at health facilities entered data directly into SORMAS, and health zone-level model, where data entry was centralized at the health zone office. Methods: From July 2022 to December 2024, SORMAS was piloted for case-based reporting of epidemic-prone diseases in the Kenge Health Zone via the facility-level model and in 13 other health zones via the health zone-level model. We evaluated the completeness and timeliness of case-based reporting, as well as concordance with the conventional paper-based weekly epidemiological reports (WERs). SORMAS user characteristics were obtained through a telephone survey. Results: A total of 2,950 cases were registered in SORMAS between July 2022 and August 2024. The completeness of non-mandatory epidemiological data exceeded 80% across both implementation models. Timely reporting (within 1 day) was significantly greater under the facility-level model (46.0%) than under the health zone-level model (5.0%). SORMAS reported more cases than WERs under facility-level implementation, whereas WERs captured more cases than SORMAS under the health zone-level model. Conclusion: SORMAS is a viable tool for enhancing disease surveillance in the DRC, particularly when implemented at the health facility level. This pilot demonstrates the potential of digital tools to improve outbreak preparedness and response in resource-limited settings.
- 19 November 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1669745
Open AccessEvaluating the performance of digital surveillance for epidemic-prone diseases in Kwango Province, Democratic Republic of Congo
Background: Strengthening infectious disease surveillance systems is critical to prevent the spread of diseases, particularly in resource-limited settings. Digital health tools such as the Surveillance Outbreak Response Management and Analysis System (SORMAS) offer real-time reporting and data management. This study assessed the performance of SORMAS in Kwango Province, Democratic Republic of Congo (DRC), focusing on two implementation models: facility-level model, where health workers at health facilities entered data directly into SORMAS, and health zone-level model, where data entry was centralized at the health zone office. Methods: From July 2022 to December 2024, SORMAS was piloted for case-based reporting of epidemic-prone diseases in the Kenge Health Zone via the facility-level model and in 13 other health zones via the health zone-level model. We evaluated the completeness and timeliness of case-based reporting, as well as concordance with the conventional paper-based weekly epidemiological reports (WERs). SORMAS user characteristics were obtained through a telephone survey. Results: A total of 2,950 cases were registered in SORMAS between July 2022 and August 2024. The completeness of non-mandatory epidemiological data exceeded 80% across both implementation models. Timely reporting (within 1 day) was significantly greater under the facility-level model (46.0%) than under the health zone-level model (5.0%). SORMAS reported more cases than WERs under facility-level implementation, whereas WERs captured more cases than SORMAS under the health zone-level model. Conclusion: SORMAS is a viable tool for enhancing disease surveillance in the DRC, particularly when implemented at the health facility level. This pilot demonstrates the potential of digital tools to improve outbreak preparedness and response in resource-limited settings.
- Open Access
- 11 January 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (2) , 480
Urbanization and Waterborne Pathogen Emergence in Low-Income Countries: Where and How to Conduct Surveys?
A major forthcoming sanitary issue concerns the apparition and spreading of drug-resistant microorganisms, potentially threatening millions of humans. In low-income countries, polluted urban runoff and open sewage channels are major sources of microbes. These microbes join natural microbial communities in aquatic ecosystems already impacted by various chemicals, including antibiotics. These composite microbial communities must adapt to survive in such hostile conditions, sometimes promoting the selection of antibiotic-resistant microbial strains by gene transfer. The low probability of exchanges between planktonic microorganisms within the water column may be significantly improved if their contact was facilitated by particular meeting places. This could be specifically the case within biofilms that develop on the surface of the myriads of floating macroplastics increasingly polluting urban tropical surface waters. Moreover, as uncultivable bacterial strains could be involved, analyses of the microbial communities in their whole have to be performed. This means that new-omic technologies must be routinely implemented in low- and middle-income countries to detect the appearance of resistance genes in microbial ecosystems, especially when considering the new ‘plastic context.’ We summarize the related current knowledge in this short review paper to anticipate new strategies for monitoring and surveying microbial communities.
- 11 January 2020
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (2) , 480
Open AccessUrbanization and Waterborne Pathogen Emergence in Low-Income Countries: Where and How to Conduct Surveys?
A major forthcoming sanitary issue concerns the apparition and spreading of drug-resistant microorganisms, potentially threatening millions of humans. In low-income countries, polluted urban runoff and open sewage channels are major sources of microbes. These microbes join natural microbial communities in aquatic ecosystems already impacted by various chemicals, including antibiotics. These composite microbial communities must adapt to survive in such hostile conditions, sometimes promoting the selection of antibiotic-resistant microbial strains by gene transfer. The low probability of exchanges between planktonic microorganisms within the water column may be significantly improved if their contact was facilitated by particular meeting places. This could be specifically the case within biofilms that develop on the surface of the myriads of floating macroplastics increasingly polluting urban tropical surface waters. Moreover, as uncultivable bacterial strains could be involved, analyses of the microbial communities in their whole have to be performed. This means that new-omic technologies must be routinely implemented in low- and middle-income countries to detect the appearance of resistance genes in microbial ecosystems, especially when considering the new ‘plastic context.’ We summarize the related current knowledge in this short review paper to anticipate new strategies for monitoring and surveying microbial communities.
- Open Access
- 4 December 2018
- Published by Springer Nature in Trials
- Vol. 19 (1) , 666
A multicenter, randomized controlled comparison of three renutrition strategies for the management of moderate acute malnutrition among children aged from 6 to 24 months (the MALINEA project)
The aim of this open-label, randomized controlled trial conducted in four African countries (Madagascar, Niger, Central African Republic, and Senegal) is to compare three strategies of renutrition for moderate acute malnutrition (MAM) in children based on modulation of the gut microbiota with enriched flours alone, enriched flours with prebiotics or enriched flours coupled with antibiotic treatment. To be included, children aged between 6 months and 2 years are preselected based on mid-upper-arm circumference (MUAC) and are included based on a weight-for-height Z-score (WHZ) between − 3 and − 2 standard deviations (SD). As per current protocols, children receive renutrition treatment for 12 weeks and are assessed weekly to determine improvement. The primary endpoint is recovery, defined by a WHZ ≥ − 1.5 SD after 12 weeks of treatment. Data collected include clinical and socioeconomic characteristics, side effects, compliance and tolerance to interventions. Metagenomic analysis of gut microbiota is conducted at inclusion, 3 months, and 6 months. The cognitive development of children is evaluated in Senegal using only the Developmental Milestones Checklist II (DMC II) questionnaire at inclusion and at 3, 6, and 9 months. The data will be correlated with renutrition efficacy and metagenomic data. This study will provide new insights for the treatment of MAM, as well as original data on the modulation of gut microbiota during the renutrition process to support (or not) the microbiota hypothesis of malnutrition. ClinicalTrials.gov, ID: NCT03474276 Last update 28 May 2018.
- 4 December 2018
- Published by Springer Nature in Trials
- Vol. 19 (1) , 666
Open AccessA multicenter, randomized controlled comparison of three renutrition strategies for the management of moderate acute malnutrition among children aged from 6 to 24 months (the MALINEA project)
The aim of this open-label, randomized controlled trial conducted in four African countries (Madagascar, Niger, Central African Republic, and Senegal) is to compare three strategies of renutrition for moderate acute malnutrition (MAM) in children based on modulation of the gut microbiota with enriched flours alone, enriched flours with prebiotics or enriched flours coupled with antibiotic treatment. To be included, children aged between 6 months and 2 years are preselected based on mid-upper-arm circumference (MUAC) and are included based on a weight-for-height Z-score (WHZ) between − 3 and − 2 standard deviations (SD). As per current protocols, children receive renutrition treatment for 12 weeks and are assessed weekly to determine improvement. The primary endpoint is recovery, defined by a WHZ ≥ − 1.5 SD after 12 weeks of treatment. Data collected include clinical and socioeconomic characteristics, side effects, compliance and tolerance to interventions. Metagenomic analysis of gut microbiota is conducted at inclusion, 3 months, and 6 months. The cognitive development of children is evaluated in Senegal using only the Developmental Milestones Checklist II (DMC II) questionnaire at inclusion and at 3, 6, and 9 months. The data will be correlated with renutrition efficacy and metagenomic data. This study will provide new insights for the treatment of MAM, as well as original data on the modulation of gut microbiota during the renutrition process to support (or not) the microbiota hypothesis of malnutrition. ClinicalTrials.gov, ID: NCT03474276 Last update 28 May 2018.